Paul Averback Insider Profile

4 Followers
Paul Averback, CEO, Director, Ten Percent Owner at Nymox Pharmaceutical, holds 23.33M shares in Nymox Pharmaceutical (Ticker: NYMXF). Most recently, Paul Averback Sold $100,000 shares of Nymox Pharmaceutical on Nov 06, 2018 for an estimated value of 175.00K.
tipranks
Paul Averback

Paul Averback
Nymox Pharmaceutical (NYMXF)
CEO, Director, Ten Percent Owner

Ranked #43,748 out of 99,218 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+9.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
A breakdown of Paul Averback's holdings

Insider Roles

Nymox Pharmaceutical
(NYMXF)
CEO, Director, Ten Percent Owner
Roles that Paul Averback holds in companies

Most Profitable Insider Trade

Stock:
Nymox Pharmaceutical
(NYMXF)
Rating:Informative Sell
Date:Nov 06, 2018 - Nov 06, 2019
Return:+9.50%
The most profitable trade made by Paul Averback

Paul Averback's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Nymox Pharmaceutical
Nov 06, 2018
CEO, Director, Ten Percent Owner
Informative Sell
175.00K
$1.17M
Success Rate for
NYMXF
2 out of 2 profitable transactions on
NYMXF
100%
Average Return for
NYMXF
Average return per transaction on
NYMXF
+9.50%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 06, 2018
Informative Sell
$175.00K
-
$1.75
+9.50%
Nov 06, 2018
Informative Sell
$4.22M
-
$2.50
+9.50%
List of latest transactions for each holding click on a transaction to see Paul Averback's performance on stock

Paul Averback insider profile FAQ

What is the percentage of profitable transactions made by Paul Averback?
The percentage of profitable transactions made by Paul Averback is 100%.
    What is the average return per transaction made by Paul Averback?
    The average return per transaction made by Paul Averback is 9.50%.
      What stocks does Paul Averback hold?
      Paul Averback holds: NYMXF stocks.
        What was Paul Averback’s latest transaction?
        Paul Averback latest transaction was an Informative Sell of $175.00K.
          What was Paul Averback's most profitable transaction?
          Paul Averback’s most profitable transaction was an Informative Sell of NYMXF stock on November 6, 2018. The return on the trade was 9.50%.
            What is Paul Averback's role in Nymox Pharmaceutical?
            Paul Averback's role in Nymox Pharmaceutical is CEO, Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.